Work

Quadruplet Induction, Autologous Transplantation and Minimal Residual Disease Adapted Consolidation and Treatment Cessation in Older Adults ≥70y with Newly Diagnosed Multiple Myeloma: A Subgroup Analysis of the Master Trial

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-160381

Authors: Smith Giri, Saurabh Chhabra, Eva Medvedova, Bhagirathbhai Dholaria, Timothy Martin Schmidt, Kelly N. Godby, Rebecca Silbermann, Binod Dhakal, Susan Bal, Anita D'Souza, Aric C. Hall, Pamela Hardwick, Jim Omel, Robert Frank Cornell, Natalie Callander, Parameswaran Hari, Luciano J. Costa

Institutions: University of Alabama at Birmingham, Medical College of Wisconsin, Oregon Health & Science University, OHSU Knight Cancer Institute, Vanderbilt University Medical Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, UAB Medicine, University of Alabama at Birmingham Hospital, Vanderbilt University, University of Wisconsin System

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310128079

FWCI: 0.183

Cites:

Cited by: 1

Related to: 10